Attached files

file filename
10-K - FORM 10-K - MABVAX THERAPEUTICS HOLDINGS, INC.d846215d10k.htm
EX-3.8 - EX-3.8 - MABVAX THERAPEUTICS HOLDINGS, INC.d846215dex38.htm
EX-4.12 - EX-4.12 - MABVAX THERAPEUTICS HOLDINGS, INC.d846215dex412.htm
EX-4.11 - EX-4.11 - MABVAX THERAPEUTICS HOLDINGS, INC.d846215dex411.htm
EX-4.13 - EX-4.13 - MABVAX THERAPEUTICS HOLDINGS, INC.d846215dex413.htm
EX-10.15 - EX-10.15 - MABVAX THERAPEUTICS HOLDINGS, INC.d846215dex1015.htm
EX-10.30 - EX-10.30 - MABVAX THERAPEUTICS HOLDINGS, INC.d846215dex1030.htm
EX-10.29 - EX-10.29 - MABVAX THERAPEUTICS HOLDINGS, INC.d846215dex1029.htm
EX-32.1 - EX-32.1 - MABVAX THERAPEUTICS HOLDINGS, INC.d846215dex321.htm
EX-99.1 - EX-99.1 - MABVAX THERAPEUTICS HOLDINGS, INC.d846215dex991.htm
EX-32.2 - EX-32.2 - MABVAX THERAPEUTICS HOLDINGS, INC.d846215dex322.htm
EX-31.2 - EX-31.2 - MABVAX THERAPEUTICS HOLDINGS, INC.d846215dex312.htm
EX-31.1 - EX-31.1 - MABVAX THERAPEUTICS HOLDINGS, INC.d846215dex311.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the registration statements on Form S-8 (Nos. 333-44826, 333-58020, 333-118614, 333-135396, 333-161132 and 333-174355) and Form S-3 (No. 333-176121), of MabVax Therapeutics Holdings, Inc., of our report dated March 31, 2015, related to our audit of the consolidated financial statements of MabVax Therapeutics Holdings, Inc., as of December 31, 2014 and 2013 and for the years then ended, which report included an explanatory paragraph relating to Mabvax Therapeutics, Inc.’s ability to continue as a going concern, included in this Annual Report on Form 10-K.

/s/ CohnReznick LLP

 

San Diego, California
March 31, 2015